Table 4.
Primary Extrahepatic Bile Duct Lymphomas Reported in Literature
| Diagnosis | No. of cases |
Age range (mean) |
Gender | Gall stones |
Regional adenopathy |
References |
|---|---|---|---|---|---|---|
| DLBCL and other aggressive B-NHLs* |
7 | 34 – 68 (49) |
4F, 3M | 1/4, 3NA |
1/6, 1NA | (33, 36) (41, 63) (41) (46) (21) (10) |
| FL | 4 | 33 – 53 (43) |
3F, 1M | 0/1, 3NA |
0/4 | (16, 60) (2) (40) |
| EBV-PTLD | 2 | 41, 59 | 1F, 1M | NA | 0/2 | (5) |
| EMZL | 1 | 59 | M | NA | 0/1 | (58) |
| T-NHL, NOS | 1 | 25 | F | NA | 0/1 | (15) |
| NHL, NOS | 1 | 48 | M | NA | 0/1 | (64) |
*
Includes one T-cell histiocyte rich large B-cell lymphoma (10)
DLBCL – diffuse large B-cell lymphoma; FL – follicular lymphoma; EBV-PTLD – EBV-related post-transplantation lymphoproliferative disorder; EMZL – extranodal marginal zone lymphoma; NA – not available; NHL – non-Hodgkin lymphoma; TCHRBCL –